3003 ORAL Cetuximab plus irinotecan in patients (pts) with metastatic colorectal cancer (mCRC) failing prior oxaliplatin-based therapy: the EPIC trial
暂无分享,去创建一个
W. Scheithauer | H. Lenz | A. Zubel | H. Burris | J. Maurel | G. Middleton | M. Lutz | A. Sobrero | M. Saleh | K. Williams | M. Saleh